Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance
November 24, 2021 13:24 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) has received written notification (the "Nasdaq Notice")...
The National Institute for Health and Care Excellence of The United Kingdom Provides Positive Guidance for Neovasc Reducer System
November 24, 2021 09:34 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the United Kingdom’s...
Neovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 09, 2021 16:21 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Nov. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire --Neovasc, Inc.("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today reported financial results for the third quarter...
Neovasc to Report Third Quarter 2021 Financial Results on November 9, 2021
November 01, 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER, Nov. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (NASDAQ, TSX: NVCN), will report financial results for the quarter ended September 30, 2021 on Tuesday, November 9, 2021....
Neovasc Reducer™ Featured in Polish Heart Journal
October 21, 2021 09:05 ET
|
Neovasc, Inc.
Publication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery VANCOUVER and MINNEAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc....
Neovasc REDUCER-I Study Published in EuroIntervention Journal
September 28, 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced the publication of an article...
Neovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference
September 23, 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Sept. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ,TSX: NVCN) today announced that its management team will be...
Neovasc Announces FDA Approval of COSIRA-II Clinical Trial
September 16, 2021 09:05 ET
|
Neovasc, Inc.
Company on Schedule to Commence Trial Late This Year VANCOUVER and MINNEAPOLIS, Sept. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN)...
Neovasc to Participate in H.C. Wainwright & Co. 23rd Annual Global Investment Conference
August 30, 2021 16:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ,TSX: NVCN) today announced that its management team will be...
Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDA
August 17, 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today that it has filed a supplement to the...